Join to View Full Profile
3130 Highland AveCincinnati, OH 45219
Phone+1 513-584-4268
Fax+1 513-584-6955
Dr. Curran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2012 - 2015- University of ChicagoResidency, Internal Medicine, 2008 - 2011
Stanford University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2019 - 2027
IL State Medical License 2011 - 2020
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsClinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report.Joshua F Zeidner, Jayanshu Jain, Rina Li Welkie, Ying Huang, Ronan T Swords
Blood Advances. 2026-04-14 - Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive...Razan Mohty, Ravi Narra, Alice S Mims, Cameron Hunter, Rory M Shallis
Leukemia & Lymphoma. 2026-04-09 - 5 citationsRecognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of ...Emily Curran, Marlise R Luskin, Houda Alachkar, Ibrahim Aldoss, Patrick W Burke
Haematologica. 2025-12-01
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinEmily K Curran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabEmily K Curran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Blood Cancer Healing Center Marks First Anniversary with Holistic Care ApproachJuly 28th, 2025- Multi-Institutional Team Awarded NCI Grant to Open Novel AML TrialJune 23rd, 2025
- Ponatinib and Blinatumomab Combination Safe and Effective in Patients with Newly Diagnosed, Ph-Positive ALLFebruary 3rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
